Shawn C Aylward1, Amanda L Way2. 1. Department of Neurology, Nationwide Children's Hospital, The Ohio State University College of Medicine, 700 Children's Drive, Columbus, OH, 43205, USA. Shawn.Aylward@nationwidechildrens.org. 2. Department of Ophthalmology, Nationwide Children's Hospital, Columbus, OH, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to provide an update on pediatric intracranial hypertension. RECENT FINDINGS: The annual pediatric incidence is estimated at 0.63 per 100,000 in the USA and 0.71 per 100,000 in Britain. The Idiopathic Intracranial Hypertension Treatment Trial found improvement in visual fields, optical coherence tomography, Frisen grade, and quality of life with acetazolamide compared to placebo in adult patients, and these findings have been translated to the pediatric population. Pediatric intracranial hypertension is a disorder that if left untreated can lead to poor quality of life and morbidity. There are no current treatment studies in pediatrics, but adult data suggests acetazolamide remains an acceptable first-line medication.
PURPOSE OF REVIEW: The purpose of this review is to provide an update on pediatric intracranial hypertension. RECENT FINDINGS: The annual pediatric incidence is estimated at 0.63 per 100,000 in the USA and 0.71 per 100,000 in Britain. The Idiopathic Intracranial Hypertension Treatment Trial found improvement in visual fields, optical coherence tomography, Frisen grade, and quality of life with acetazolamide compared to placebo in adult patients, and these findings have been translated to the pediatric population. Pediatric intracranial hypertension is a disorder that if left untreated can lead to poor quality of life and morbidity. There are no current treatment studies in pediatrics, but adult data suggests acetazolamide remains an acceptable first-line medication.
Authors: S B Carter; M Pistilli; K G Livingston; D R Gold; N J Volpe; K S Shindler; G T Liu; M A Tamhankar Journal: Eye (Lond) Date: 2014-09-05 Impact factor: 3.775
Authors: Robert A Avery; Samir S Shah; Daniel J Licht; Jeffrey A Seiden; Jimmy W Huh; Jan Boswinkel; Michael D Ruppe; Amber Chew; Rakesh D Mistry; Grant T Liu Journal: N Engl J Med Date: 2010-08-26 Impact factor: 91.245
Authors: Yim-Yee Matthews; Fiona Dean; Ming J Lim; Karen Mclachlan; Alan S Rigby; Guirish A Solanki; Catharine P White; William P Whitehouse; Colin R Kennedy Journal: Arch Dis Child Date: 2017-03-29 Impact factor: 3.791
Authors: Süreyya Burcu Görkem; Selim Doğanay; Mehmet Canpolat; Gonca Koc; Mehmet S Dogan; Hüseyin Per; Abdülhakim Coşkun Journal: Childs Nerv Syst Date: 2014-10-31 Impact factor: 1.475
Authors: Alexandra J Sinclair; Michael A Burdon; Peter G Nightingale; Alexandra K Ball; Peter Good; Timothy D Matthews; Andrew Jacks; Mark Lawden; Carl E Clarke; Paul M Stewart; Elizabeth A Walker; Jeremy W Tomlinson; Saaeha Rauz Journal: BMJ Date: 2010-07-07
Authors: Justin Schwarz; Ali Al Balushi; Sri Sundararajan; Marc Dinkin; Cristiano Oliveira; Jeffrey P Greenfield; Athos Patsalides Journal: Interv Neuroradiol Date: 2020-11-25 Impact factor: 1.610
Authors: Nieves Martín-Begué; Eduard Mogas; Charlotte Wolley Dod; Silvia Alarcón; María Clemente; Ariadna Campos-Martorell; Ana Fábregas; Diego Yeste Journal: J Clin Res Pediatr Endocrinol Date: 2020-10-02